Mary Alice Dwyer, PharmD is Vice President, US, for Synetic Life Sciences, providing strategic solutions to Medical Affairs teams in the pharmaceutical and biotech industry. Mary Alice is an experienced enterprise-wide and global Medical Affairs leader with expertise in creating transformational change initiatives, building and leading effective teams, and implementing patient-centric practices. Most recently she was Vice President, Global Medical Excellence (GME), an organization that she developed and led, whose remit was to elevate Medical Affairs deliverables via global, regional, and local medical partnerships while ensuring strong governance processes. She recently accepted the role of Chair of the MAPS Executive Program Committee. In this effort she will be working with the Focus Area Working Groups to deliver strategic content to support high impact Medical Affairs teams. Mary Alice is passionate about the opportunity for digital transformation in Medical Affairs and she is also the Chair of the Medical Affairs Digital Strategy Council, which brings together Medical Affairs leaders from across the industry to better understand the practical applications of modern technology.

Mary Alice also held roles as head of US Field Medical and VP of US Medical Affairs while at AstraZeneca. In addition, she has led scientific and medical teams at Takeda, Pharmacia, and Searle and worked in clinical drug development at Hoffmann-LaRoche and Glaxo. Mary Alice received a bachelor’s degree (B.S.) in Pharmacy from the University of Rhode Island and a doctorate in pharmacy (Pharm.D.) and Pediatric specialty residency from the University of Texas Health Science Center at San Antonio, and a Post-doc fellowship at Rutgers University and Hoffmann-LaRoche.